BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 34946849)

  • 21. Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer.
    McLeod AB; Stice JP; Wardell SE; Alley HM; Chang CY; McDonnell DP
    Prostate; 2018 Mar; 78(4):266-277. PubMed ID: 29243324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATM‑JAK‑PD‑L1 signaling pathway inhibition decreases EMT and metastasis of androgen‑independent prostate cancer.
    Zhang L; Xu LJ; Zhu J; Li J; Xue BX; Gao J; Sun CY; Zang YC; Zhou YB; Yang DR; Shan YX
    Mol Med Rep; 2018 May; 17(5):7045-7054. PubMed ID: 29568923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unravelling the molecular mechanisms of prostate cancer evolution from genotype to phenotype.
    Tong D
    Crit Rev Oncol Hematol; 2021 Jul; 163():103370. PubMed ID: 34051300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FOXC2 expression and epithelial-mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer.
    Børretzen A; Gravdal K; Haukaas SA; Beisland C; Akslen LA; Halvorsen OJ
    J Pathol Clin Res; 2019 Oct; 5(4):272-286. PubMed ID: 31464093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling.
    Zhang Z; Xu Y
    Mol Med; 2022 Jul; 28(1):82. PubMed ID: 35854234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer.
    Chang YT; Lin TP; Campbell M; Pan CC; Lee SH; Lee HC; Yang MH; Kung HJ; Chang PC
    Sci Rep; 2017 Mar; 7():42795. PubMed ID: 28256535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dependence of castration-resistant prostate cancer (CRPC) stem cells on CRPC-associated fibroblasts.
    Adisetiyo H; Liang M; Liao CP; Jeong JH; Cohen MB; Roy-Burman P; Frenkel B
    J Cell Physiol; 2014 Sep; 229(9):1170-6. PubMed ID: 24752784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms.
    Liu YN; Yin JJ; Abou-Kheir W; Hynes PG; Casey OM; Fang L; Yi M; Stephens RM; Seng V; Sheppard-Tillman H; Martin P; Kelly K
    Oncogene; 2013 Jan; 32(3):296-306. PubMed ID: 22370643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumours.
    Sackmann Sala L; Boutillon F; Menara G; De Goyon-Pélard A; Leprévost M; Codzamanian J; Lister N; Pencik J; Clark A; Cagnard N; Bole-Feysot C; Moriggl R; Risbridger GP; Taylor RA; Kenner L; Guidotti JE; Goffin V
    J Pathol; 2017 Sep; 243(1):51-64. PubMed ID: 28603917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tpl2 induces castration resistant prostate cancer progression and metastasis.
    Lee HW; Cho HJ; Lee SJ; Song HJ; Cho HJ; Park MC; Seol HJ; Lee JI; Kim S; Lee HM; Choi HY; Nam DH; Joo KM
    Int J Cancer; 2015 May; 136(9):2065-77. PubMed ID: 25274482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
    Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
    Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation.
    Markopoulos GS; Roupakia E; Marcu KB; Kolettas E
    Cells; 2019 Sep; 8(10):. PubMed ID: 31557902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
    Shiota M; Itsumi M; Takeuchi A; Imada K; Yokomizo A; Kuruma H; Inokuchi J; Tatsugami K; Uchiumi T; Oda Y; Naito S
    Endocr Relat Cancer; 2015 Dec; 22(6):889-900. PubMed ID: 26311513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition.
    Liu YN; Abou-Kheir W; Yin JJ; Fang L; Hynes P; Casey O; Hu D; Wan Y; Seng V; Sheppard-Tillman H; Martin P; Kelly K
    Mol Cell Biol; 2012 Mar; 32(5):941-53. PubMed ID: 22203039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal Evolution and Epithelial Plasticity in the Emergence of AR-Independent Prostate Carcinoma.
    Laudato S; Aparicio A; Giancotti FG
    Trends Cancer; 2019 Jul; 5(7):440-455. PubMed ID: 31311658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
    Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of hypoxia on the acquisition of epithelial-mesenchymal transition and cancer stemness: a possible link to epigenetic regulation.
    Yeo CD; Kang N; Choi SY; Kim BN; Park CK; Kim JW; Kim YK; Kim SJ
    Korean J Intern Med; 2017 Jul; 32(4):589-599. PubMed ID: 28704917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer.
    Gupta S; Vanderbilt C; Abida W; Fine SW; Tickoo SK; Al-Ahmadie HA; Chen YB; Sirintrapun SJ; Chadalavada K; Nanjangud GJ; Bialik A; Morris MJ; Scher HI; Ladanyi M; Reuter VE; Gopalan A
    Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):507-516. PubMed ID: 32094488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-644a Disrupts Oncogenic Transformation and Warburg Effect by Direct Modulation of Multiple Genes of Tumor-Promoting Pathways.
    Ebron JS; Shankar E; Singh J; Sikand K; Weyman CM; Gupta S; Lindner DJ; Liu X; Campbell MJ; Shukla GC
    Cancer Res; 2019 Apr; 79(8):1844-1856. PubMed ID: 30808676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying global expression patterns and key regulators in epithelial to mesenchymal transition through multi-study integration.
    Parsana P; Amend SR; Hernandez J; Pienta KJ; Battle A
    BMC Cancer; 2017 Jun; 17(1):447. PubMed ID: 28651527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.